Tc 99m EC20

DRUG5 trials

Sponsors

Endocyte

Conditions

Bladder CancerEndometrial CancerHead and Neck CancerHealthy VolunteersMetastatic Renal Cell CarcinomaOvarian CancerOvarian CarcinomaPancreas Cancer

Phase 1

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer

CompletedNCT01686256

EndocyteEndometrial Cancer, Ovarian Cancer

Start: 2001-08-31Updated: 2023-06-22

Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients

CompletedNCT01689636

EndocyteHealthy Volunteers, Ovarian Cancer

Start: 2000-08-31End: 2002-07-31Updated: 2023-06-22

Phase 2

Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor

CompletedNCT01684098

EndocyteBladder Cancer, Head and Neck Cancer, Pancreas Cancer +2

Start: 2003-08-31End: 2005-08-31Target: 40Updated: 2023-06-22

Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma

CompletedNCT01689714

EndocyteOvarian Carcinoma, Recurrent Endometrial Carcinoma

Start: 2003-08-31End: 2005-08-31Updated: 2023-06-22

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma

CompletedNCT01689662

EndocyteMetastatic Renal Cell Carcinoma

Start: 2002-08-31End: 2003-07-31Updated: 2023-06-22